Clinical Hypnosis for Fibromyalgia and Autoimmune Disorders

$65.00

Presented by Louis F. Damis, PhD, ABPP, FASCH

Friday, July 11, 2025

9am-10:30am PT/ 11am-12:30pm CT/ 12pm-1:30pm ET

Event held online via Zoom, link to access provided upon registration.

Clinical hypnosis has reliably been found to produce both short- and long-term treatment benefits for disorders of gut-brain interaction. Moreover, similar hypnotic approaches have also been found to be of benefit to the treatment of chronic pain and autoimmune disorders.

This presentation will review the empirical evidence supporting the effectiveness of clinical hypnosis strategies for the treatment of fibromyalgia and autoimmune disorders. A history of adverse childhood experiences, trauma, and PTSD symptoms has been found to be antecedent or concurrent with these conditions. Moreover, fibromyalgia and autoimmune disorders are frequently shown to have low levels of HRV consistent with the effects of trauma on the ANS. Consequently, ANS dysregulation and its impact on immune, endocrine, motor, and pain processing systems is a common etiological and perpetuating factor. Furthermore, trauma-related symptoms comorbid with these disorders are associated with greater levels of pain, symptom severity and duration, and disability. Research will be reviewed on the treatment of these disorders, selection of the relevant treatment targets, and setting of appropriate outcome goals.

Zoom link will be available on course page in “My Courses” upon event registration. 

This program, when attended in its entirety, offers 1.5 CEs for Psychologists, 1.5 IL CEUS for Counselors and Social Workers, or 1.5 BBS California CEUs for LPCCs, LPSWs, and LMFTs.

Click here to view full course information.


Disclaimer for all sessions: Courses may take up to one hour to populate in “My Courses” after purchase. Purchase of a session within one hour of a program start time may not guarantee access to the live session. We strongly encourage registering as early as possible to ensure live session and Zoom link access.

Description

Presented by Louis F. Damis, PhD, ABPP, FASCH

Friday, July 11, 2025

9am-10:30am PT/ 11am-12:30pm CT/ 12pm-1:30pm ET

Event held online via Zoom, link to access provided upon registration.

Clinical hypnosis has reliably been found to produce both short- and long-term treatment benefits for disorders of gut-brain interaction. Moreover, similar hypnotic approaches have also been found to be of benefit to the treatment of chronic pain and autoimmune disorders.

This presentation will review the empirical evidence supporting the effectiveness of clinical hypnosis strategies for the treatment of fibromyalgia and autoimmune disorders. A history of adverse childhood experiences, trauma, and PTSD symptoms has been found to be antecedent or concurrent with these conditions. Moreover, fibromyalgia and autoimmune disorders are frequently shown to have low levels of HRV consistent with the effects of trauma on the ANS. Consequently, ANS dysregulation and its impact on immune, endocrine, motor, and pain processing systems is a common etiological and perpetuating factor. Furthermore, trauma-related symptoms comorbid with these disorders are associated with greater levels of pain, symptom severity and duration, and disability. Research will be reviewed on the treatment of these disorders, selection of the relevant treatment targets, and setting of appropriate outcome goals.

Zoom link will be available on course page in “My Courses” upon event registration. 

This program, when attended in its entirety, offers 1.5 CEs for Psychologists, 1.5 IL CEUS for Counselors and Social Workers, or 1.5 BBS California CEUs for LPCCs, LPSWs, and LMFTs.

Click here to view full course information.


Disclaimer for all sessions: Courses may take up to one hour to populate in “My Courses” after purchase. Purchase of a session within one hour of a program start time may not guarantee access to the live session. We strongly encourage registering as early as possible to ensure live session and Zoom link access.